Description

Genotropin 36 IU contains somatropin, a biosynthetic form of human growth hormone produced using recombinant DNA technology. It is identical to endogenous GH and is prescribed to replace deficient hormone levels.

The therapy supports normal growth in pediatric patients and helps maintain metabolic balance, muscle mass, bone density, and overall well-being in adults with confirmed GHD. Treatment is individualized and requires ongoing medical monitoring.

Usage Instructions

Use only as prescribed by a qualified healthcare professional

Administer via subcutaneous injection using the approved delivery device

Follow the prescribed dose and schedule precisely

Rotate injection sites to reduce local reactions

⚠️ Training on injection technique and dose adjustment is essential.

Medicinal Advantages

Replaces deficient human growth hormone

Supports normal growth in children with GHD

Helps improve body composition and bone health in adults

Clinically validated recombinant formulation

Enables individualized dosing under specialist care

Clinical endocrinology guidelines support somatropin therapy for approved indications.

Possible Side Effects

Some patients may experience:

Injection site reactions (redness, swelling)

Headache or joint pain

Fluid retention or edema

Changes in blood glucose levels

Serious adverse effects are uncommon but require prompt medical evaluation.